Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- European Society of Cardiology: cardiovascular disease statistics 2019.Eur Heart J. 2020; 41: 12-85https://doi.org/10.1093/eurheartj/ehz859
- Cardiovascular disease in Europe 2014: epidemiological update.Eur Heart J. 2014; 35: 2950-2959
- A decade of changes in clinical characteristics and management of elderly patients with non-ST elevation myocardial infarction admitted in Italian cardiac care units.Open Heart. 2014; 13 (1)e000148
- Contemporary trends and age-specific sex differences in management and outcome for patients with ST-segment elevation myocardial infarction.J Am Heart Assoc. 2016; 5e004202
- Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome.Eur Heart J. 2020; 41: 1328-1336
- Sex differences in survival after myocardial infarction in Sweden, 1987-2010.Heart. 2017; 103: 1625-1630
- Sex differences in outcomes after STEMI: effect modification by treatment strategy and age.JAMA Intern Med. 2018; 178: 632-639
- Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial.JACC Cardiovasc Interv. 2012; 5: 906-916https://doi.org/10.1016/j.jcin.2012.06.008
- Age at menopause and extent of coronary artery disease among postmenopausal women with acute coronary syndromes.Am J Med. 2016; 129: 1205-1212https://doi.org/10.1016/j.amjmed.2016.05.031
- Comparison of reduced dose prasugrel and standard dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revaacularization.Circulation. 2018; 137: 2435-2445https://doi.org/10.1161/CIRCULATIONAHA.117.032180
- Age at menopause, extent of coronary artery disease and outcome among postmenopausal women with acute coronary syndromes.Int J Cardiol. 2018; 259: 8-13
- Acute myocardial infarction in women: a scientific statement from the American Heart Association.Circulation. 2016; 133: 916-947
- Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction.Am J Med. 2012; 125: 1000-1009
- Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction.JAMA. 2012; 308: 998-1006
- Temporal trends and sex differences in revascularization and outcomes of ST-segment elevation myocardial infarction in younger adults in the United States.J Am Coll Cardiol. 2015; 66: 1961-1972
- Age-stratified sex disparities in care and outcomes in patients with ST-elevation myocardial infarction.Am J Med. 2020; 133: 1293-1301.e1https://doi.org/10.1016/j.amjmed.2020.03.059
- Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes.Am J Cardiol. 2009; 103: 1530-1536
- The impact of increased age on outcome from a strategy of early invasive management and revascularisation in patients with acute coronary syndromes: retrospective analysis study from the ACACIA registry.BMJ Open. 2012; 2e000540
- Effects of age on long- term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials.Heart. 2012; 98: 207-213https://doi.org/10.1136/heartjnl-2011-300453
- Sex-related outcomes in elderly patients presenting with non-ST segment elevation acute coronary syndrome: insights from the Italian Elderly ACS Study.JACC Cardiovasc Interv. 2015; 8: 791-796https://doi.org/10.1016/j.jcin.2014.12.240
- Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation.Atherosclerosis. 2013; 230: 12-16
- Relation of gender to infarct size in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty.Am J Cardiol. 2013; 111: 936-940
- Causes of death in elderly patients with non-ST-elevation acute coronary syndrome.Am J Cardiol. 2013; 112: 1-7
- Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study.Am Heart J. 2004; 148: 852-856https://doi.org/10.1016/j.ahj.2004.05.018
- Age and sex differences in hospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR((R)).Am Heart J. 2014; 167: 376-383
- Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry.Circ Cardiovasc Interv. 2009; 2: 423-429
- Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial.Am Heart J. 2013; 166: 723-728
Funding: The Italian Elderly ACS study was promoted by the Italian Society of Interventional Cardiology (SICI-GISE) and the Italian Federation of Cardiology (FIC), and endorsed by the Italian Association of Hospital Cardiologists (ANMCO), and cofinanced by liberal contributions of The Medicines Company, Italy. The Ladies ACS study has been promoted, managed, and coordinated by Istituto di Ricerca e Cura a Carattere Scientifico Arcispedale Santa Maria Nuova in Reggio Emilia, Italy, and cofinanced by liberal contributions and research grants from Novartis Farma, Italy. The Elderly ACS 2 study has been promoted, managed, and coordinated by Istituto di Ricerca e Cura a Carattere Scientifico Arcispedale Santa Maria Nuova in Reggio Emilia, Italy, and cofinanced by liberal contributions and research grants from Eli Lilly and Daiichi Sankyo. Some of the sponsor responsibilities were delegated to the Clinical Research Organization Mediolanum Cardio Research (Milan, Italy). The funders of the studies had no role in study design, data collection, data analysis, or writing of the present report.
Conflicts of Interest: NM reports grants from Getinge Global and personal fees from Bristol Meyers Squibb. LDL reports personal fees from Amgen, Aspen, Astra Zeneca, Bayer, Boehringer Ingelheim, Chiesi, Eli Lilly, Daiichi Sankyo, Pharmevo, Menarini, The Medicines Company. DG reports personal fees from Pfizer, Sanofi Aventis, and Boehringer Ingelheim. ASP reports personal fees from Medtronic, Boston, and Abbott. LP reports personal fees from Volcano Europe. SDS reports personal fees from Astra Zeneca, Eli Lilly, Bristol Meyer Squibb, Merck Sharp & Dohme, Sonfi, and Pfizer. SS reports grants from Novartis, Eli Lilly, Correvio and personal fees from Astra Zeneca, Bayer, Bristol Meyer Squib, and Pfizer. RDR, GDL, LAF, GT, NF, LM, PS, MC, RA, CC, LL, CL, EM, AR, MF, EC, DC, FP, FP, GG report none.
Authorship: All authors had access to the data and a role in writing this manuscript.